MTIC
CSTL icon

Missouri Trust & Investment Company’s Castle Biosciences CSTL Stock Holding History

Missouri Trust & Investment Company’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$466 Hold
19
– – ﹤0.01% 399
2025
Q4 		$739 Hold
19
– – ﹤0.01% 388
2025
Q3 		$433 Hold
19
– – ﹤0.01% 399
2025
Q2 		$388 Hold
19
– – ﹤0.01% 412
2025
Q1 		$380 Hold
19
– – ﹤0.01% 401
2024
Q4 		$506 Hold
19
– – ﹤0.01% 418
2024
Q3 		$542 Hold
19
– – ﹤0.01% 376
2024
Q2 		$414 Hold
19
– – ﹤0.01% 391
2024
Q1 		$421 Hold
19
– – ﹤0.01% 399
2023
Q4 		$410 Hold
19
– – ﹤0.01% 418
2023
Q3 		$321 Hold
19
– – ﹤0.01% 413
2023
Q2 		$261 Hold
19
– – ﹤0.01% 460
2023
Q1 		$432 Hold
19
– – ﹤0.01% 347
2022
Q4 		$1K Hold
19
– – ﹤0.01% 313
2022
Q3 		$1K Hold
19
– – ﹤0.01% 323
2022
Q2 		$1K Hold
19
– – ﹤0.01% 336
2022
Q1 		$1K Hold
19
– – ﹤0.01% 332
2021
Q4 		$1K Buy
+19
New +$993 ﹤0.01% 375

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Missouri Trust & Investment Company's CSTL Position: Q1 2026 in Review

Missouri Trust & Investment Company held its Castle Biosciences (CSTL) position steady in Q1 2026 at 19 shares worth $466. The position accounts for ﹤0.01% of the portfolio, ranked #399.

Missouri Trust & Investment Company first reported a position in CSTL in Q4 2021 and has held it in 18 quarters since. The position peaked at $1K in Q4 2022. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Missouri Trust & Investment Company held 19 shares of Castle Biosciences worth $466 as of Q1 2026.
  • Missouri Trust & Investment Company left its Castle Biosciences share count unchanged in Q1 2026.
  • Castle Biosciences made up ﹤0.01% of Missouri Trust & Investment Company's portfolio in Q1 2026, its #399 holding.
  • Missouri Trust & Investment Company first reported a position in Castle Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Missouri Trust & Investment Company's Castle Biosciences position peaked at $1K in Q4 2022.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.